ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

July 26, 2002

After A One-Month Retirement, Becker Returns To M.D. Anderson As Research Prof.

November 30, 2001

DCCP Board Gives Concept Approval to Noncompeting Contracts

June 17, 1983

Cancer Congress Program Developed

June 27, 1980

Carbone to Give Up ECOG Chairmanship; DCE’s Adamson Receives Presidential Executive Award

October 6, 1989

HHS Forms Rural Task Force To Study, Improve Programs.

July 27, 2001